首页 > 市场调查报告书 > 医疗设备

e保健医院 IT

市场调查报告书

商品编码

1419129

数位药局市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按药物类型、产品、平台和地理位置

Digital Pharmacy Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Type, Product, Platform, and Geography

出版日期: 2023年11月17日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

数位药局市场预计将从2022年的964.28亿美元成长到2030年的3,638.78亿美元；预计2022年至2030年CAGR为18.1%。

COVID-19 大流行期间在线购买处方药的激增以及人们越来越倾向于在线平台是推动数位药房市场成长的几个因素。

数位药房是一家获得许可的药房，涵盖透过个人风格将高科技和高效解决方案相结合的实体，有助于将新的、现有的和数位疗法商业化。此解决方案简化了配药流程，增强了利害关係人的体验，并为生物製药製造商提供了可行的见解来阐明处方流程。例如，数位药局可以帮助生物製药公司消除障碍，使配药药局能够获得干净且可立即配药的处方。

市场趋势

创新电子药局模式

根据 SHOPS Plus 2019 年 12 月发布的报告，透过私营部门 (SHOPS) Plus 维持健康成果

印度的专案团队宣布与中央邦政府和製药公司 Medlife International 合作，推出创新的药物到家电子药房模式来对抗结核病 (TB)。 SHOPS Plus Prohect 团队设计了服务交付模式，透过电子药局模式/平台加强结核病服务。例如，在印度，结核病疫情正在下降。然而，该国仍拥有最多的结核病患者，每年有 50 万例未确诊。因此，SHOP Plus正致力于利用科技，透过电子药局模式，为患者提供上门诊断和治疗支援服务。 SHOP Plus 的此类措施将有助于增加患者获得结核病服务的机会。透过SHOP Plus专案设计的电子药局平台，结核病患者可以为结核病患者开立居家痰液检测材料，并且检测是远端完成的。电子药房代理将提取材料并将其运送到实验室设施。痰液材料处理完毕后，实验室会将病患的检测报告上传至电子药局平台。结核病患者可以查看报告，医生可以为患者开立治疗处方。该电子药房平台还采用通讯技术来追踪患者的治疗依从性和未来的订单。这种创新的电子药局模式将为 2020-2030 年预测期内的成长提供利润丰厚的市场机会。

市场趋势

基于网路的整合线上药局介面成为主要趋势

整合电子医疗保健系统与药剂师和患者可以存取的基于网路的药房介面相结合，可能会成为未来几年数位药房市场的新趋势。线上药局为购买药品的人提供线上支援的程式就是此类介面的一个显着例子。例如，服用他汀类药物作为治疗的一部分的患者可能会停止服药或出现服药不规则的情况。与接受过培训的药房团队成员进行提醒和即时聊天，为服用他汀类处方药的人提供依从性支持，可以帮助避免停药。

基于平台的见解

从平台来看，数位药局市场分为应用程式平台和网站平台。基于应用程式的应用程式进一步细分为远距医疗药房应用程式、药物管理应用程式、健康和保健应用程式、复合药房应用程式等。基于应用程式的细分市场将在 2022 年占据更大的市场份额，预计该细分市场在预测期内的复合CAGR将达到 17.60%。预计 2022 年至 2030 年期间，远距医疗药房应用程式将占据基于应用程式细分市场的最大份额。可以从任何地方透过远距医疗应用程式存取虚拟医疗保健。根据 CDC 2021 年发布的资料，2020 年有 37.0% 的成年人使用远距医疗，包括医疗服务提供者就诊、线上处方和心理健康服务。最好的远距医疗应用程式可以免费下载并且易于使用，而且它们通常完全涵盖保险服务。远距医疗药局应用程式的一些范例包括 Hims & Hers、GoodRx、K Health 和 Doctor on Demand。 GoodRx 提供低成本就诊、透过电子邮件轻鬆补充处方以及无需健康保险的就诊等服务。

根据药品类型，数位药局市场分为处方药和非处方药。处方药细分市场将在 2022 年占据更大的市场份额，预计该细分市场在预测期内的复合CAGR将达到 17.83%。根据产品，数位药局市场分为个人护理、维生素和补充剂、药品和治疗以及其他产品。药物和治疗领域进一步分为性健康、神经系统疾病、心臟照护、糖尿病、减重等。药物和治疗领域在 2022 年占据更大的市场份额，预计该领域在预测期内的CAGR将达到 17.87%。从平台来看，数位药局市场分为应用程式平台和网站平台。基于应用程式的应用程式进一步细分为远距医疗药房应用程式、药物管理应用程式、健康和保健应用程式、复合药房应用程式等。基于应用程式的细分市场将在 2022 年占据更大的市场份额，预计该细分市场在预测期内的复合CAGR将达到 17.60%。按性别划分，市场分为男性和女性。到 2022 年，女性细分市场将占据更大的市场份额，预计该细分市场在预测期内的复合CAGR将达到 17.64%。

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 11 章：Covid-19 前后的影响

第 12 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第13章：竞争格局

关键参与者的热图分析
公司定位与专注

第 14 章：数位药局市场 - 主要公司概况

Alto

注意 - 将为以下公司列表提供类似信息

药包
胶囊
CVS健康
信诺
沃尔格林公司
沃尔玛公司
亚马逊公司
克罗格公司
好接收器

第 15 章：附录

词彙表
关于 Insight Partners
市场情报云

简介目录

Product Code: TIPRE00031438

The digital pharmacy market is expected to grow from US$ 96.428 billion in 2022 to US$ 363.878 billion by 2030; it is expected to grow at a CAGR of 18.1% from 2022 to 2030.

Upsurge in online purchase of prescription medicines during the COVID-19 pandemic and an increasing inclination toward online platforms are a few factors driving the digital pharmacy market growth.

A digital pharmacy is a licensed pharmacy covering an entity combining high-tech and efficient solutions through a personal touch that helps commercialize new, existing, and digital therapies. The solution simplifies the process of filling a prescription, enhances stakeholders' experiences, and clarifies the prescription journey with actionable insights for biopharma manufacturers. For example, digital pharmacies can help biopharma companies remove barriers, enabling dispensing pharmacies to receive clean and ready-to-dispense prescriptions.

Market Trend

Innovative E-Pharmacy Model

According to the published report by SHOPS Plus in December 2019, Sustaining Health Outcomes through the Private Sector (SHOPS) Plus

The project team in India announced a partnership with the State Government of Madhya Pradesh and the pharmaceutical company Medlife International to launch an innovative, drug-to-doorstep e-pharmacy model to fight against tuberculosis (TB). The SHOPS Plus Prohect team designed the service delivery model to strengthen the TB services through an e-pharmacy model/platform. For example, in India, the TB epidemic is declining. However, the country still holds the most significant number of TB patients, with half a million cases carried undiagnosed annually. Therefore, SHOP Plus is working to utilize technology to provide diagnosis and treatment support services available at the patient's doorstep through an e-pharmacy model. Such initiatives by SHOP Plus will help to increase access to TB services among patients. With the e-pharmacy platform designed by the SHOP Plus project, TB patients can prescribe home sputum testing materials for TB patients, and the test is completed remotely. The e-pharmacy agent will pick up the material and deliver it to the lab facility. After processing the sputum material, the lab will upload the patient's testing report on the e-pharmacy platform. TB patients can view the report, and physicians can prescribe the treatment for the patient. The e-pharmacy platform also features communication technology to follow up with patients' treatment adherence and future orders. Such innovative e-pharmacy models will provide lucrative market opportunities for growth in the forecast period 2020-2030.

Market Trend

Integrated Web-Based Online Pharmacy Interface Emerges as Key Trend

Integrated e-healthcare systems incorporated with web-based pharmacy interfaces that are accessible to pharmacists and patients are likely to emerge as new trends in the digital pharmacy market in the coming years. Programs made available by online pharmacies to provide online support to people buying medicines are a notable example of such interfaces. For instance, patients administered with statins as a part of their treatments are likely to discontinue or show irregularities in taking medicines. Reminders and live chat with a pharmacy team member trained in providing adherence support to people consuming statin-based prescribed medicines can help avoid the discontinuation of doses.

Platform-Based Insights

In terms of platform, the digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. Telehealth pharmacy apps are expected to account for a maximum share of the market for the app-based segment during 2022-2030. Virtual healthcare can be accessed through telehealth apps from anywhere. According to CDC data published in 2021, 37.0% of adults used telemedicine in 2020, including provider visits, online prescriptions, and mental health services. The best telehealth apps can be downloaded free of cost and are easy to use, and they often completely cover insurance services. A few examples of telehealth pharmacy apps are Hims & Hers, GoodRx, K Health, and Doctor on Demand. GoodRx offers services such as low-cost visits, easy prescription refills via mail, and visits without health insurance.

Based on drug type, the digital pharmacy market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.83% during the forecast period. Based on product, the digital pharmacy market is segmented into personal care, vitamins & supplements, medicines & treatments, and other products. The medicine & treatments segment is further segregated as sexual health, neurological disorders, heart care, diabetes, weight loss, and others. The medicine and treatment segment held a larger market share in 2022, and the segment is anticipated to register a higher CAGR of 17.87% during the forecast period. In terms of platform, the digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. By gender, the market is bifurcated into males and females. The females segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.64% during the forecast period.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Digital Pharmacy Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Digital Pharmacy Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Digital Pharmacy Market - Global Market Analysis

6.1 Digital Pharmacy - Global Market Overview
6.2 Digital Pharmacy - Global Market and Forecast to 2030

7. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Drug Type, 2020-2030

7.1 Overview
7.2 Prescription Medicines
7.3 Over the Counter Products

8. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Products, 2020-2030

8.1 Overview
8.2 Medicine
8.3 Personal Care
8.4 Vitamins and Supplements
8.5 Others

9. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Platform, 2020-2030

9.1 Overview
9.2 Apps
9.3 Websites

10. Digital Pharmacy Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Digital Pharmacy Market Overview
- 10.1.2 North America Digital Pharmacy Market Revenue and Forecasts to 2030
- 10.1.3 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Drug Type
- 10.1.4 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Products
- 10.1.5 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Platform
- 10.1.6 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Digital Pharmacy Market
    - 10.1.6.1.1 United States Digital Pharmacy Market, by Drug Type
    - 10.1.6.1.2 United States Digital Pharmacy Market, by Products
    - 10.1.6.1.3 United States Digital Pharmacy Market, by Platform
  - 10.1.6.2 Canada Digital Pharmacy Market
    - 10.1.6.2.1 Canada Digital Pharmacy Market, by Drug Type
    - 10.1.6.2.2 Canada Digital Pharmacy Market, by Products
    - 10.1.6.2.3 Canada Digital Pharmacy Market, by Platform
  - 10.1.6.3 Mexico Digital Pharmacy Market
    - 10.1.6.3.1 Mexico Digital Pharmacy Market, by Drug Type
    - 10.1.6.3.2 Mexico Digital Pharmacy Market, by Products
    - 10.1.6.3.3 Mexico Digital Pharmacy Market, by Platform

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

14. Digital Pharmacy Market - Key Company Profiles

14.1 Alto
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies